The melanoma-treating drug, selumetinib (red) is bound to its protein target MEK1 (blue).
Credit
Dr. Lucky Tran
Usage Restrictions
Please use image credit.
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.